{"id":"NCT02290821","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied Four Times Daily in Subjects With Acute Blunt Soft Tissue Injuries/Contusions of the Limbs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2015-09","completion":"2015-09","firstPosted":"2014-11-14","resultsPosted":"2017-04-19","lastUpdate":"2017-04-19"},"enrollment":215,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Blunt Soft Tissue Injuries/Contusions"],"interventions":[{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"Placebos","otherNames":[]}],"arms":[{"label":"diclofenac sodium gel 1%","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will assess the analgesic efficacy of DSG 1% compared to placebo in the reduction of the pain associated with acute blunt trauma injuries.","primaryOutcome":{"measure":"Sum of Pain Intensity Differences Over 24 Hours After Initiating Treatment (SPID 24)","timeFrame":"24 hours","effectByArm":[{"arm":"Diclofenac Sodium Gel 1%","deltaMin":42.9,"sd":40.6},{"arm":"Placebo","deltaMin":45.5,"sd":42.6}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":109},"commonTop":["headache"]}}